SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ZEO and Pluri Agree to Expand U.S. Regenerative Medicine Platform

ZEO and Pluri entered into a definitive strategic agreement to expand their U.S. manufacturing and commercialization platform. Specific operating terms were not disclosed.

ZEOX

Related stories